First Eagle Investment Management, LLC - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 36 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
First Eagle Investment Management, LLC ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q4 2015$346,000
-43.5%
200,000
-38.6%
0.00%
-50.0%
Q3 2015$612,000
-19.7%
325,5590.0%0.00%0.0%
Q2 2015$762,000
+52.1%
325,559
+184.4%
0.00%
+100.0%
Q1 2015$501,000
-9.2%
114,4560.0%0.00%0.0%
Q4 2014$552,000
+16.0%
114,4560.0%0.00%0.0%
Q3 2014$476,000
-29.4%
114,4560.0%0.00%
-50.0%
Q2 2014$674,000
-30.9%
114,456
-25.1%
0.00%
-33.3%
Q1 2014$975,000152,8000.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q1 2014
NameSharesValueWeighting ↓
TWO SIGMA SECURITIES, LLC 49,360$9,0000.01%
Burt Wealth Advisors 2,625$1,0000.00%
LAZARD ASSET MANAGEMENT LLC 75,000$13,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 76,678$13,0000.00%
Geneva Advisors, LLC 52,471$9,0000.00%
GUGGENHEIM CAPITAL LLC 21,865$4,0000.00%
BlackRock Investment Management, LLC 1,485$00.00%
MYCIO WEALTH PARTNERS, LLC 12,000$2,0000.00%
Bank of New York Mellon Corp 32,196$5,0000.00%
HighTower Advisors, LLC 27,870$5,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders